SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/EB8FD8F5B13EE0EF0B220D2EBF6000D067E53AD546F5E57D65F4F9147D1F8DF09FF719CA8242308B5AADD9B73E6B4A67>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/EB8FD8F5B13EE0EF0B220D2EBF6000D067E53AD546F5E57D65F4F9147D1F8DF09FF719CA8242308B5AADD9B73E6B4A67
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/EB8FD8F5B13EE0EF0B220D2EBF6000D067E53AD546F5E57D65F4F9147D1F8DF09FF719CA8242308B5AADD9B73E6B4A67
http://www.w3.org/2000/01/rdf-schema#comment
"Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9."
xsd:string
http://purl.uniprot.org/uniprot/#_B6B54AFC75254651E9B383EBAFE9E2C266FDE0D13105208D7D3FB930788A733414563DA9BE43C49DB511AA9F18A62772
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/EB8FD8F5B13EE0EF0B220D2EBF6000D067E53AD546F5E57D65F4F9147D1F8DF09FF719CA8242308B5AADD9B73E6B4A67
http://purl.uniprot.org/uniprot/B4DSG3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EB8FD8F5B13EE0EF0B220D2EBF6000D067E53AD546F5E57D65F4F9147D1F8DF09FF719CA8242308B5AADD9B73E6B4A67
http://purl.uniprot.org/uniprot/#_B4DSG3-mappedCitation-35188403
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EB8FD8F5B13EE0EF0B220D2EBF6000D067E53AD546F5E57D65F4F9147D1F8DF09FF719CA8242308B5AADD9B73E6B4A67